EC Healthcare (HKG:2138)
Hong Kong · Delayed Price · Currency is HKD 0.4200
-0.0050 (-1.18%)
Aug 12, 2026, 3:52 PM HKT
EC Healthcare Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 3,770 | 4,140 | 4,211 | 3,875 | 2,920 |
| 3,770 | 4,140 | 4,211 | 3,875 | 2,920 | |
Revenue Growth | -8.94% | -1.68% | 8.66% | 32.74% | 40.33% |
Cost of Revenue | 2,658 | 2,890 | 2,881 | 2,614 | 1,734 |
Gross Profit | 1,113 | 1,250 | 1,330 | 1,261 | 1,185 |
Selling, General & Admin | 565.5 | 595.7 | 599.48 | 560.33 | 426.8 |
Amortization of Goodwill & Intangibles | 92.11 | 118.18 | 108.92 | 97.77 | 71.38 |
Other Operating Expenses | 27.11 | 31.35 | -4.32 | -4.71 | -5.42 |
Operating Expenses | 1,105 | 1,258 | 1,221 | 1,142 | 853.75 |
Operating Income | 7.72 | -8.11 | 109.58 | 119.04 | 331.67 |
Interest Expense | -71.67 | -90.7 | -100.84 | -63.64 | -48.91 |
Interest & Investment Income | 16.09 | 17.63 | 17.22 | 4.87 | 1.36 |
Earnings From Equity Investments | 8.5 | -95.43 | 5.43 | 12.33 | -0.67 |
Other Non Operating Income (Expenses) | 13.18 | 19.96 | 36.93 | 32.72 | 18.54 |
EBT Excluding Unusual Items | -26.18 | -156.65 | 68.32 | 105.33 | 301.99 |
Merger & Restructuring Charges | - | -0.67 | -0.48 | -0.28 | -1.21 |
Impairment of Goodwill | - | - | - | -7.48 | - |
Gain (Loss) on Sale of Investments | -4.13 | -16.86 | -24.58 | -19.09 | -11.57 |
Gain (Loss) on Sale of Assets | 22.49 | 266.92 | -1.84 | 3.64 | 19.12 |
Asset Writedown | -409.77 | -194.18 | -26.38 | 2.2 | 10.8 |
Other Unusual Items | 7.42 | 0.3 | 1.83 | 51.88 | 2.28 |
Pretax Income | -410.16 | -101.14 | 16.87 | 136.19 | 321.41 |
Income Tax Expense | 2.71 | 10.78 | 1.18 | 29.16 | 50.91 |
Earnings From Continuing Operations | -412.87 | -111.92 | 15.7 | 107.03 | 270.5 |
Minority Interest in Earnings | 10.15 | -55.27 | -34.64 | -37.37 | -73 |
Net Income | -402.72 | -167.19 | -18.95 | 69.65 | 197.5 |
Net Income to Common | -402.72 | -167.19 | -18.95 | 69.65 | 197.5 |
Net Income Growth | - | - | - | -64.73% | 2.40% |
Shares Outstanding (Basic) | 1,185 | 1,185 | 1,185 | 1,181 | 1,153 |
Shares Outstanding (Diluted) | 1,185 | 1,185 | 1,185 | 1,184 | 1,173 |
Shares Change | - | - | 0.08% | 0.94% | 13.79% |
EPS (Basic) | -0.34 | -0.14 | -0.02 | 0.06 | 0.17 |
EPS (Diluted) | -0.34 | -0.14 | -0.02 | 0.06 | 0.17 |
EPS Growth | - | - | - | -64.88% | -10.16% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 547.87 | 686.07 | 527.88 | 194.27 | 348.09 |
Free Cash Flow Per Share | 0.46 | 0.58 | 0.45 | 0.16 | 0.30 |
Dividend Per Share | - | 0.010 | 0.005 | 0.100 | 0.144 |
Dividend Growth | - | 100.00% | -95.00% | -30.56% | -9.43% |
Gross Margin | 29.51% | 30.19% | 31.59% | 32.55% | 40.60% |
Operating Margin | 0.21% | -0.20% | 2.60% | 3.07% | 11.36% |
Profit Margin | -10.68% | -4.04% | -0.45% | 1.80% | 6.77% |
Free Cash Flow Margin | 14.53% | 16.57% | 12.54% | 5.01% | 11.92% |
EBITDA | 248.99 | 325.73 | 392.44 | 352.13 | 497.07 |
EBITDA Margin | 6.60% | 7.87% | 9.32% | 9.09% | 17.03% |
D&A For EBITDA | 241.27 | 333.83 | 282.86 | 233.08 | 165.41 |
EBIT | 7.72 | -8.11 | 109.58 | 119.04 | 331.67 |
EBIT Margin | 0.21% | -0.20% | 2.60% | 3.07% | 11.36% |
Effective Tax Rate | - | - | 6.99% | 21.41% | 15.84% |